Professor of Medicine Section BMT and Leukemia
Oncology
Dr. Camille N. Abboud, MD
|
|
Give Review
Camille Abboud practices Oncology. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Camille N. Abboud has written publications. He has 41 publications published with PubMed. The lastest paper is: 'Peri-transplant serum albumin decline predicts subsequent severe acute graft-versus-host disease following mucotoxic myeloablative conditioning.' Camille Abboud is registered with Medicare and accepts Medicare payments.
Publications
- Peri-transplant serum albumin decline predicts subsequent severe Acute graft-versus-host disease following mucotoxic myeloablative conditioning.
- Acute myeloid leukemia presenting with extensive bone marrow necrosis, leukemia cutis and testicular involvement: successful treatment with allogeneic hematopoietic st...
- Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F.
- A phase II study of V-BEAM as conditioning regimen before second auto-SCT for multiple Myeloma.
- Haploidentical transplantation using G-CSF-mobilized T-Cell replete PBSCs and post-transplantation CY after non-myeloablative conditioning is safe and is associated wi...
- A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.
- Phase I study of cladribine, cytarabine, granulocyte colony stimulating factor (CLAG regimen) and midostaurin and all-trans retinoic acid in relapsed/refractory AML.
- Phase I study of oral clofarabine consolidation in adults aged 60 and older with Acute myeloid leukemia.
- Chronic myelogenous Leukemia, version 1.2014.
- Protective Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients Is Influenced by Co...
- Acute Myeloid Leukemia, Version 2.2013.
- A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML.
- Chronic myelogenous Leukemia. Clinical practice guidelines in oncology.
- Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and Acute myeloid leukemia: A phase I study.
- Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin Lymphoma treated with standard salvage chemotherapy and autologous stem cell transplanta...
- Acute myeloid leukemia.
- A phase 2 study of high-dose lenalidomide as initial therapy for older patients with Acute myeloid leukemia.
- A Phase I Trial: Dose Escalation of Melphalan in the 'BEAM' Regimen Using Amifostine Cytoprotection.
- Control of plasma uric acid in adults at risk for tumor Lysis Syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared wit...
- Salvage therapy for Acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
- A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic Syndromes.
- Cladribine in the treatment of Acute myeloid leukemia: a single-institution experience.
- Another nail in the AML coffin.
- Single-agent lenalidomide induces complete remission of Acute myeloid leukemia in patients with isolated trisomy 13.
- Induction therapy for elderly patients with Acute myeloid leukemia.
- Unlocking the dysplasia puzzle.
- Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (G...
- Impact of mobilization and remobilization strategies on achieving sufficient stem Cell yields for autologous transplantation.
- Rapid method for detection of mutations in the nucleophosmin gene in Acute myeloid leukemia.
- Effects of AMD3100 on transmigration and survival of Acute myelogenous leukemia cells.
- Apoptosis and complement-mediated lysis of myeloma Cells by polyclonal rabbit antithymocyte globulin.
- Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition.
- Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative Disorders.
- Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic s...
- Donor cell myelodysplastic Syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature review.
- A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with Acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.
- Flavonoid effects on normal and leukemic Cells.
- Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem Cell transplant recipients.
- The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologo...
- Optimal cytokine stimulation for the enhanced generation of leukemic dendritic Cells in short-term culture.
Schools
American University Of Beirut
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
American University of Beirut Faculty of Medicine
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1316965320 | |
| NPPES Provider LastName | ABBOUD | |
| NPPES Provider FirstName | CAMILLE | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Hematology | |
| Total Claim Count | 1111.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 52.0 | |
| Percent Opioid Claims | 4.68 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316965320 |
| Last Name Of The Provider | ABBOUD |
| First Name Of The Provider | CAMILLE |
| View All |
Similar Doctors
|
|
Priyanka Raval |
|
|
Dr. Vikram C. Gorantla, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy P. Rearden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ron Bose, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia X. Ma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Taneemul Haque, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles S. Eby, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Bruce J. Roth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Christopher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Iskra Pusic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul J. Petruska, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy A. Graubert, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|